AWAshlie Watters

Ashlie Watters

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ashlie Watters has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Myocardial mechanics and cardiac biomarkers in adults with severe anorexia nervosa

    by Mori J. Krantz, Ashlie Watters, Judy Oakes, Megan Frazier, Philip S. Mehler

    Background Anorexia nervosa (AN) is associated with left ventricular (LV) atrophy and unexplained sudden death. Myocardial mechanics have not been well studied in adults with AN. Whether LV mass or illness duration, markers of AN severity, correlate with abnormal strain imaging is unknown. Methods We performed a prospective study among patients hospitalized with severe AN (n = 29) [body mass index (BMI) < 14.5 kg/m2] and sex/age-matched controls (n = 16) (BMI > 18.5 kg/m2). LV ejection fraction (LVEF) was calculated via modified-biplane method and LV mass was derived using the truncated ellipsoid formula. Apical 2-, 3-, and 4-chamber images were used to generate regional strain mapping and global longitudinal strain (GLS). N-terminal brain natriuretic peptide (NT-proBNP) levels were measured and linear regression was used to determine independent predictors of strain. Results Mean LVEF did not differ (65% ± 6.0 vs. 62% ± 4.4, p = 0.06), but LV mass was substantially reduced (61.6 ± 16.8 vs. 97.6 ± 19.1 g, p < .0001). GLS was similar (− 20.6 ± 3.8 vs. − 20.9 ± 2.8, p = 0.82), however, the basal strain was worse (-18.7 ± 4.8 vs. -21.9 ± 4.1, p = 0.03). Lower LV mass was associated with worsening GLS (r = − 0.40, p = 0.003), but not among controls (p = 0.89). Median (IQR) NT-proBNP (pg/ml) was higher in patients with AN [141 (59–257) vs. 35.5 (21–56.5) p = 0.0007]. Both increasing NT-proBNP and illness duration were associated with worsening strain patterns in AN (both p = .001). Conclusions While LVEF and GLS did not differ, regional strain variation was noted among patients with AN. Elevated NT-proBNP may reflect increased wall tension from LV atrophy. Whether strain heterogeneity can identify patients with AN, at risk for sudden death, requires further study.


  • Seizures in eating disorders

    by Dennis Gibson, Ashlie Watters, Maryrose Bauschka

    Objective: To complete a descriptive study of seizure etiology in a large population of eating disorder (ED) patients and to better understand whether malnutrition itself, in those with EDs, is associated with seizure development.Method: In this retrospective study, 75 patients with documented seizures met inclusion criteria from a total of 1664 charts.Results: Prevalence of seizures in this ED cohort was found to be 4.5%, with 29.3% of individuals experiencing seizures due to psychogenic nonepileptic seizures (PNES). Other common causes of seizures included substance abuse/withdrawal (18.7%), primary seizure disorder (12%), and electrolyte abnormalities/hypoglycemia (10.7%). Three patients (4%) also developed their seizures presumably due to Wernicke's encephalopathy (WE).Discussion: Several etiologies of seizures are reported from this large sample of ED patients, and this is also the first study to report on a possible association of WE as a cause of seizures in ED patients. The contribution of WE and malnutrition toward the development of seizures in this population remains to be determined, and future studies should also seek to better understand the inter‐relationship between malnutrition and the other variables discussed in this article, such as hypomagnesemia, toward seizure development.Public significance: The medical complications of EDs are myriad but seizures have not historically been considered one of those direct complications of malnutrition. The findings of this retrospective study suggest that seizure development may be a direct and indirect complication associated with EDs. The presentation of Wernicke's encephalopathy, which can also be associated with development of seizures, requires further investigation in those with EDs.


  • Clinical features of adult patients with avoidant/restrictive food intake disorder presenting for medical stabilization: A descriptive study

    by Allison Nitsch, Ashlie Watters, Jamie Manwaring, Maryrose Bauschka, Melanie Hebert, Philip S. Mehler

    Objective: The purpose of this study is to describe the clinical features of adult patients with avoidant/restrictive food intake disorder (ARFID) to better understand the medical findings, psychological comorbidities, and laboratory abnormalities in this population.Method: We completed a retrospective chart review of all adult patients with a diagnosis of ARFID, admitted for medical stabilization, between April 2016 and June 2021, to an inpatient hospital unit, which specializes in severe eating disorders. Information collected included anthropomorphic data, laboratory assessments, and medical history at time of admission.Results: One hundred and twenty‐two adult patients with ARFID were identified as meeting inclusion criteria for the study. The most common ARFID presentation was “fear of adverse consequences.” The majority were female (70%), with an average age of 32.7 ± 13.7 years and mean percent of ideal body weight (m%IBW) of 68.2 ± 10.9. The most common laboratory abnormalities were low serum prealbumin and vitamin D, hypokalemia, leukopenia, and elevated serum bicarbonate. The most common psychiatric diagnoses were anxiety and depressive disorders, and the most common medical diagnoses were disorders of gut–brain interaction (DGBI).Discussion: This is the largest study to the authors' knowledge of medical presentations in adult patients with ARFID. Our results reflect that the adult patient with ARFID may, in some aspects, present differently than pediatric and adolescent patients with ARFID, or from ARFID patients requiring less intensive care. This study highlights the need for further investigation of adult patients with ARFID.Public Significance: ARFID is a restrictive eating disorder first defined in 2013. This study explores the medical presentations of adult patients (>18 years old) with ARFID presenting for specialized eating disorder treatment and identifies unique features of the adult presentation for treatment, compared to pediatric and adolescent peers.


  • Retracted
    Open Access

    RETRACTED ARTICLE: Causes of death in patients with a history of severe anorexia nervosa

    by Patricia Westmoreland, Alan Duffy, Renee Rienecke, Daniel Le Grange, Thomas Joiner, Jamie Manwaring, Ashlie Watters, Philip Mehler

    This study reports causes of death for a cohort of 35 patients with severe anorexia nervosa (AN), who were treated between 2012 and 2020, and descriptive information on their medical and psychological comorbidities is provided. Three hundred and seventy patient names were submitted to the National Death Index (NDI). The NDI reviewed whether a death certificate matching each patient’s identifying information existed, and if it existed, specific causes of death were noted. The original group of 370 patients consisted of 229 individuals who had been treated voluntarily and 141 who had been treated involuntarily. Thirty-five patients, from the 370 (9.4%) submitted to the NDI, with an initial diagnosis of AN, were confirmed deceased. Most (83%) were female with an average age of 38.5 years (SD:12.7) and average body mass index (BMI) of 12.8 kg/m2 (SD:2.4). The total number of patients, with AN listed as a cause of death, was 24 (69%). Two patients died as a result of suicide. Twenty-eight (80%) of the patients had a specific medical disease listed as a cause of death, with the most frequent being cardiovascular, metabolic, or gastrointestinal. AN is associated with a substantial risk of death from many medical causes. However, two (5.7%) of our sample died by suicide, a rate considerably lower than previously reported. This is a study reporting on causes of death in a cohort of 35 patients with severe anorexia nervosa (AN), who were treated between 2012 and 2020. Three hundred and seventy patient names were submitted to the National Death Index (NDI). The NDI reviewed whether a death certificate matching each patient’s identifying information existed, and if it existed, specific causes of death were noted. The original group of 370 patients consisted of 229 individuals who had been treated voluntarily and 141 who had been treated involuntarily. Thirty-five of the 370 patients (9.4%) submitted to the NDI were confirmed deceased. Eighty-three percent were female with an average age of 38.5 years (SD:12.7) and average body mass index (BMI) of 12.8 kg/m2 (SD:2.4). The total number of patients with AN listed as a cause of death was 24 (69%). Twenty-eight (80%) of the patients had a specific medical disease listed as a cause of death, with the most frequent being cardiovascular, metabolic, or gastrointestinal. Two patients died as a result of suicide. We concluded that AN is associated with a substantial risk of death from many medical causes. However, two (5.7%) of our sample died by suicide, a rate considerably lower than previously reported.


  • Assessing the Impact of Weighted Blankets on Anxiety Among Patients With Anorexia Nervosa and Avoidant– Restrictive Food Intake Disorder: A Randomized Controlled Trial

    by Rachel Ohene, Christina Logan, Figaro Loresto, Ashlie Watters, Kathryn Eron, Tasha Markovchick, Philip S. Mehler

    Importance: Interventions to reduce anxiety are needed for patients with anorexia nervosa (AN) and avoidant– restrictive food intake disorder (ARFID). Weighted blankets are one such intervention. Objective: To evaluate the impact of weighted blankets on anxiety for patients with AN and ARFID. Design: Randomized controlled trial conducted between November 2018 and March 2019. Patients were randomized into the control group or the intervention group. Setting: Inpatient setting; medical stabilization unit. Participants: Patients (N = 23) diagnosed with AN or ARFID and experiencing moderate anxiety. The majority were female (91%), with a mean age of 26 yr (SD = 9.3), and the mean length of hospitalization was 22 days (SD = 17.3). Interventions: Control group participants received usual care, which included occupational therapy services. Intervention group participants received a weighted blanket along with usual care. Outcomes and Measures: Mixed-effects regression models were conducted. Primary outcomes included improvement in Beck Anxiety Inventory (BAI) scores by discharge. Results: Intervention group patients had a greater, non–statistically significant decrease in BAI score over time (B = 1.16, p = .83) than control group patients. Conclusions and Relevance: Weighted blankets may be an effective tool for reducing anxiety among patients with AN or ARFID. What This Article Adds: The use of a weighted blanket, in conjunction with occupational therapy interventions, is potentially a beneficial non-pharmacological option for patients with anorexia nervosa (AN) and avoidant–restrictive food intake disorder (ARFID). The current study adds an additional modality to the multidisciplinary treatment approach for eating disorders.


  • Gastric dilatation in patients with restrictive eating disorders

    by Dennis Gibson, Ashlie Watters, Elizabeth Dee, Philip S. Mehler

    Objectives: To better understand gastric dimensions in patients diagnosed with restrictive eating disorders (EDs).Method: In this retrospective study, 56 patients, with restrictive EDs, and 60 gender/age/race‐matched patients from an outpatient clinic, were studied. Difference in stomach size, between cohorts, was ascertained, and regression analyses were used to examine associations with stomach size in the ED cohort.Results: Patients with EDs were found to have significantly enlarged gastric dimensions when compared to the control group (M:14.8 cm [SD: 3.2] vs. 11.4 cm [SD: 2.9], p < .0001). Among the ED cohort, blood urea nitrogen (BUN), on the day of imaging, positively correlated with gastric dimensions (r = .43, p = .0009), while hypoalbuminemia negatively correlated with gastric dimensions (r = −.37, p = .005). BUN and albumin nadir were also significantly associated with stomach size (r2 = .26, F[2,53] = 9.46, p = .0003). There was no significant correlation between gastric dimensions and ED diagnosis, percent ideal body weight, gender, duration of illness, engagement in vomiting behaviors, diagnosis of superior mesenteric artery syndrome, or use of promotility agents.Discussion: Findings in this study suggest that malnutrition, secondary to EDs, may be associated with an enlarged stomach. The relationship between the gastric dimensions and reported GI symptoms in this population remain to be determined.Public significance: There are many physiologic changes to the gastrointestinal system that develop with malnutrition but the contribution of these physiologic changes toward the reported GI symptoms and refeeding difficulties is unclear. This is the first study to suggest that patients with malnutrition, secondary to EDs, may be associated with an enlarged stomach, and this potential relationship requires further investigation.


  • Open Access

    Methadone Blockade of Cardiac Inward Rectifier K + Current Augments Membrane Instability and Amplifies U Waves on Surface ECGs: A Translational Study

    by Michael G. Klein, Mori J. Krantz, Naheed Fatima, Ashlie Watters, Dayan Colon‐Sanchez, Robert M. Geiger, Robert E. Goldstein, Soroosh Solhjoo, Philip S. Mehler, Thomas P. Flagg, et al.

    Background: Methadone is associated with a disproportionate risk of sudden death and ventricular tachyarrhythmia despite only modest inhibition of delayed rectifier K + current ( I Kr ) , the principal mechanism of drug‐associated arrhythmia. Congenital defects of inward rectifier K + current ( I K1 ) have been linked to increased U‐wave amplitude on ECG and fatal arrhythmia. We hypothesized that methadone may also be a potent inhibitor of I K1 , contributing to delayed repolarization and manifesting on surface ECGs as augmented U‐wave integrals. Methods and Results: Using a whole‐cell voltage clamp, methadone inhibited both recombinant and native I K1 with a half‐maximal inhibitory concentration IC50) of 1.5 μmol/L, similar to that observed for I Kr block (half‐maximal inhibitory concentration of 2.9 μmol/L). Methadone modestly increased the action potential duration at 90% repolarization and slowed terminal repolarization at low concentrations. At higher concentrations, action potential duration at 90% repolarization lengthening was abolished, but its effect on terminal repolarization rose steadily and correlated with increased fluctuations of diastolic membrane potential. In parallel, patient ECGs were analyzed before and after methadone initiation, with 68% of patients having a markedly increased U‐wave integral compared with premethadone (lead V3; mean +38%±15%, P =0.016), along with increased QT and T Peak to T End intervals, likely reflective of I Kr block. Conclusions: Methadone is a potent I K1 inhibitor that causes augmentation of U waves on surface ECG. We propose that increased membrane instability resulting from I K1 block may better explain methadone’s arrhythmia risk beyond I Kr inhibition alone. Drug‐induced augmentation of U waves may represent evidence of blockade of multiple repolarizing ion channels, and evaluation of the effect of that agent on I K1 may be warranted.


  • What accounts for the high mortality of anorexia nervosa?

    by Philip S. Mehler, Ashlie Watters, Thomas Joiner, Mori J. Krantz

    The exact medical complications, leading to the well‐known high risk of death in patients with anorexia nervosa (AN), remain elusive. Such deaths are often abrupt with no satisfactory explanation. Suspected causes include cardiac QTc prolongation and, in turn, torsade de pointes (TdP). Psychotropic medications often prescribed to these patients are linked to QTc prolongation. AN is also presumed to cause heart failure due to malnutrition with increased susceptibility to QTc prolongation, and TdP, resulting in sudden cardiac death. Recent literature, however, is conflicting, and the likely cause of death may involve other cardiac abnormalities, such as low heart rate, abnormal heart rate variability, or increased QT dispersion. With an ongoing gap in research explaining the high mortality rate in AN, a compelling need to define the exact proximate causes of death in these patients remains. Because low serum potassium is the most common trigger for TdP, we postulate the early signal of sudden cardiac death, especially in patients with AN who purge, is hypokalemia. We also speculate that hypoglycemia could be a major factor in the sudden death of patients with AN as well as bradycardia or sinus arrest. A path forward to elucidate potential causes is offered.


  • Autophony in inpatients with anorexia nervosa or avoidant restrictive food intake disorder

    by Jeff Hollis, Scott Mann, Ashlie Watters, Judy Oakes, Philip S. Mehler

    Objective To assess for the prevalence of autophony, a distressing auditory symptom commonly attributed to patulous eustachian tube, in a cohort of individuals with severe malnourishment due to an eating disorder. Method A cross-sectional survey study was performed. Patients admitted for inpatient medical stabilization of an eating disorder, who were also at low body weight, were asked to complete a survey assessing aural symptoms present in the previous 24 hr, including autophony. Anthropometric data and prealbumin levels were collected. Results Of 101 patients enrolled, 43 (42.6%) reported symptoms of autophony. The presence of autophony was associated with lower serum prealbumin levels and lower body weight as measured by percentage of ideal body weight. Discussion Autophony is a commonly reported, albeit rarely discussed, symptom in individuals with severe eating disorders and correlates with degree of malnutrition.


  • Uric acid levels in adult patients with severe eating disorders

    by Ashlie Watters, Richard J. Johnson, Maryrose Bauschka, Judy Oakes, Marina Kelley, Philip S. Mehler

    Objective: To investigate serum uric acid (UA) levels in patients with extreme forms of eating disorders, at admission and discharge, following weeks of nutritional rehabilitation and weight restoration.Method: This observational study enrolled 160 patients diagnosed with anorexia nervosa restricting subtype (AN‐R), AN binge‐purge subtype (AN‐BP), or avoidant restrictive food intake disorder (ARFID). Serum UA levels were drawn on admission and discharge.Results: Most of the cohorts were admitted with serum UA levels on the lower end of normal. Mean serum uric level for women was 4.3 mg/dl (SD: 2.3). Patients diagnosed with AN‐BP had significantly higher UA levels on admission compared to patients with AN‐R and ARFID; p < .0001, η2 = 0.13. High UA levels positively correlated with purging and admission serum blood urea nitrogen (r = .5, p = .009).Discussion: Serum UA levels tended to be in the low‐normal range in most patients with severe AN‐R, but not in AN‐BP. However, levels did increase with nutritional intake and weight gain. There may be clinical value in checking UA levels on admission for patients with eating disorders.